Wolf K, Malinverni R
Department of Clinical Research, Inselspital, University of Bern, Bern, Switzerland.
Antimicrob Agents Chemother. 1999 Jun;43(6):1491-3. doi: 10.1128/AAC.43.6.1491.
Azithromycin, doxycycline, and rifampin, alone or in combination, were tested in vitro against Chlamydia pneumoniae AR-39. The combination of azithromycin plus rifampin showed the strongest activity and produced higher rates of eradication of C. pneumoniae from lung tissues than azithromycin alone in experimental mouse pneumonitis.
阿奇霉素、多西环素和利福平单独或联合使用,在体外对肺炎衣原体AR-39进行了测试。在实验性小鼠肺炎中,阿奇霉素加rifampin的组合显示出最强的活性,并且从肺组织中根除肺炎衣原体的比率高于单独使用阿奇霉素。